-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Bausch Health Companies Sees Unusually High Options Volume (NYSE:BHC)
Bausch Health Companies Sees Unusually High Options Volume (NYSE:BHC)
Bausch Health Companies Inc. (NYSE:BHC – Get Rating) was the recipient of some unusual options trading activity on Friday. Stock traders bought 22,560 put options on the company. This represents an increase of 21% compared to the average volume of 18,678 put options.
Institutional Investors Weigh In On Bausch Health Companies
Institutional investors and hedge funds have recently modified their holdings of the business. Tobam raised its stake in shares of Bausch Health Companies by 1,685.1% during the third quarter. Tobam now owns 336,774 shares of the company's stock worth $2,340,000 after buying an additional 317,908 shares during the last quarter. Assetmark Inc. grew its holdings in Bausch Health Companies by 454.3% during the second quarter. Assetmark Inc. now owns 10,421 shares of the company's stock valued at $87,000 after purchasing an additional 8,541 shares during the period. WINTON GROUP Ltd acquired a new position in Bausch Health Companies during the second quarter valued at approximately $265,000. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in Bausch Health Companies by 3.7% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 778,834 shares of the company's stock valued at $6,510,000 after purchasing an additional 27,923 shares during the period. Finally, Clearline Capital LP acquired a new position in Bausch Health Companies during the second quarter valued at approximately $12,752,000. 66.99% of the stock is owned by institutional investors.
Get Bausch Health Companies alerts:Bausch Health Companies Price Performance
Shares of NYSE BHC traded up $0.38 during trading on Friday, reaching $8.15. The company had a trading volume of 7,917,339 shares, compared to its average volume of 4,648,165. Bausch Health Companies has a 52 week low of $4.00 and a 52 week high of $26.39. The stock has a market cap of $2.95 billion, a PE ratio of 11.10, a PEG ratio of 0.11 and a beta of 0.96. The company has a debt-to-equity ratio of 48.05, a quick ratio of 0.77 and a current ratio of 1.05. The business's 50 day moving average price is $7.14 and its 200-day moving average price is $6.99.
Bausch Health Companies (NYSE:BHC – Get Rating) last announced its earnings results on Thursday, November 3rd. The company reported $0.76 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.16). The company had revenue of $2.05 billion during the quarter, compared to the consensus estimate of $2.09 billion. Bausch Health Companies had a return on equity of 942.47% and a net margin of 3.13%. Analysts expect that Bausch Health Companies will post 2.97 earnings per share for the current year.Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on shares of Bausch Health Companies in a research report on Wednesday, October 12th. They issued a "hold" rating on the stock. Five research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $10.60.
Bausch Health Companies Company Profile
(Get Rating)
Bausch Health Companies Inc, together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.
Read More
- Get a free copy of the StockNews.com research report on Bausch Health Companies (BHC)
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.
博世健康公司(紐約證券交易所代碼:BHC-GET評級)週五接受了一些不尋常的期權交易活動。股票交易員購買了該公司的22,560份看跌期權。與18,678份看跌期權的平均成交量相比,這意味著增加了21%。
機構投資者看好博世健康公司
機構投資者和對沖基金最近調整了對該公司的持股。在第三季度,Tobam將其在博世健康公司的股份增加了1,685.1%。在上個季度又購買了317,908股後,Tobam現在擁有336,774股該公司股票,價值2,340,000美元。AssetMark Inc.在第二季度增持了博世健康公司454.3%的股份。AssetMark Inc.在此期間又購買了8,541股,目前持有10,421股該公司股票,價值87,000美元。Winton Group Ltd在第二季度收購了博世健康公司的一個新頭寸,價值約265,000美元。三井住友信託控股有限公司(Sumitomo Mitsui Trust Holdings Inc.)第二季度增持博世保健公司股份3.7%。三井住友信託控股有限公司目前持有該公司778,834股股票,價值6,510,000美元,在此期間又購買了27,923股。最後,Clearline Capital LP在第二季度收購了博世健康公司的一個新頭寸,價值約為12,752,000美元。66.99%的股份由機構投資者持有。
到達博世健康公司警報:博世健康公司的價格表現
在週五的交易中,紐約證交所BHC的股價上漲了0.38美元,達到8.15美元。該公司的成交量為7917,339股,而其平均成交量為4,648,165股。博世健康公司的52周低點為4.00美元,52周高位為26.39美元。該股市值29.5億美元,本益比11.10,PEG率0.11,貝塔係數0.96。該公司的負債權益比率為48.05,速動比率為0.77,流動比率為1.05。該業務的50日移動均線價格為7.14美元,其200日移動均線價格為6.99美元。
博世健康公司(紐約證券交易所代碼:BHC-GET評級)最近一次公佈收益結果是在11月3日星期四。該公司公佈本季度每股收益為0.76美元,低於分析師普遍預期的0.92美元(0.16美元)。該公司本季度營收為20.5億美元,而市場普遍預期為20.9億美元。博世健康公司的股本回報率為942.47%,淨利潤率為3.13%。分析師預計,博世健康公司本年度的每股收益將達到2.97美元。華爾街分析師也加入進來
另外,StockNews.com在10月12日星期三的一份研究報告中對博世健康公司的股票進行了報道。他們對該股的評級為“持有”。根據MarketBeat.com的數據,五位研究分析師對該股的評級為持有,該股的平均評級為持有,平均目標價為10.60美元。
博世健康公司簡介
(獲取評級)
博世健康公司與其子公司一起開發、製造和營銷一系列藥物、醫療器械和非處方藥(OTC)產品,主要用於眼睛健康、胃腸病和皮膚病等治療領域。該公司通過五個部門經營:博士倫、沙利克斯、國際處方、正畸皮膚科和多元化產品。
閱讀更多內容
- 免費獲取StockNews.com關於博世健康公司(BHC)的研究報告
- Old Dominion是否表明Trucking正在踩剎車?
- 諾德斯特龍對零售業降價的擔憂
- 埃克森美孚股票:在Buy Point附近
- 高股息率的必和必拓認為中國推動了23年的增長
- 愛彼迎的漲幅是否會像分析師預測的那樣達到38%?
接受博世健康公司每日新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對博世健康公司和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧